跳至主要内容
临床试验/CTRI/2026/03/105968
CTRI/2026/03/105968尚未招募3 期

A randomized controlled trial of Jalaukavacharana in comparison with Serratiopeptidase in reducing inflammatory markers in Vranashopha w.s.r. Cellulitis

Shri Ayurved Mahavidyalaya, Nagpur1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2026年3月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
54
试验地点
1

研究概览

简要总结

This study will be carried out at OPD of Shalyatantra Department of Pakwasa Samnvay Rugnalaya, Shri Ayurved Mahavidyalaya, Nagpur. This is an open label randomized controlled trial aims at studying the comparison between jalaukavacharan and serratiopeptidase in reducing inflammatory marker in patients of vranashopha (cellulitis).Total 54 patients will be included and will be randomly divided into two groups i.e. Group A and Group B each containing 27 patients. Group A will be trial group where patients will receive jalaukavacharan and Group B will be the control group where patients will receive serratiopeptidase. Then patients will be observed on 1, 7th, and 14th day. All the findings will be recorded in case record form. At the end of trial,  collected data will be analyzed and result will be drawn accordingly.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed case of Amavastha and Pachyamana avastha of Vranashopha. Patient of age group between
  • 60 years. Patient fit for Raktamokshana.

排除标准

  • Pakwavastha of Vranashopha Uncontrolled systemic diseases such as HTN, DM etc.
  • Immuno-compromised patients.
  • Severe anemia.
  • Septicemia.

研究者

发起方
Shri Ayurved Mahavidyalaya, Nagpur
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Poonam Shamrao Malave

Shri Ayurved Mahavidyalaya, Nagpur

研究点 (1)

Loading locations...

相似试验

A Comparative Study to Evaluate the Effect of... | 临床试验